<DOC>
	<DOCNO>NCT00158002</DOCNO>
	<brief_summary>The objective study ass long-term safety effectiveness topiramate prevention basilar hemiplegic migraine child adolescent .</brief_summary>
	<brief_title>A Study Topiramate Pediatric Subjects With Basilar/Hemiplegic Migraine</brief_title>
	<detailed_description>This single-center , open-label study consist 3 phase : Blinded Transition Phase , Open-Label Maintenance Phase , Taper/Exit Phase . Subjects either succesfully complete CAPSS-271 protocol discontinue CAPSS-271 study due lack effectiveness complete least 2 week maintenance treatment eligible enroll .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Migraine Aura</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Must either complete DoubleBlind Phase CAPSS271 discontinue DoubleBlind Phase CAPSS271 due lack efficacy minimum 2 week maintenance treatment . Must continue meet specific inclusion criterion outline CAPSS271 . Female subject must premenarchal , surgically sterile ( hysterectomy , tubal ligation otherwise incapable pregnancy ) ; practice effective method birth control ( e.g. , intrauterine device , doublebarrier method , male partner sterilization ) study entry throughout study ; hormonal contraceptive least 3month period prior start study throughout study , practice abstinence agree continue abstinence use acceptable method contraception ( list ) sexual activity commence . In addition , female subject childbearing potential must negative urine pregnancy test OpenLabel Visit 1 ( Day 1 ) . Must able read comprehend write instruction willing complete headache record questionnaire require protocol . After full explanation study , subject , parent/legally authorize representative ( ) , must demonstrate willingness participate signing informed consent form . If applicable , pediatric subject capable give assent must sign assent form . Subjects develop painful condition headache pain . Subjects take prohibited concomitant medication ( See Concomitant Medications section ) . Subjects pregnant . Subjects liver function test ³ 2 time upper limit normal range . In investigator ’ opinion , subject poor compliance CAPSS271 study</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Basilar/Hemiplegic Migraine</keyword>
	<keyword>Prophylaxis</keyword>
</DOC>